Equities Analysts Set Expectations for Itron Q4 Earnings

Itron, Inc. (NASDAQ:ITRI) – Investment analysts at Zacks Research dropped their Q4 2026 earnings per share (EPS) estimates for Itron in a research report issued to clients and investors on Tuesday, May 19th. Zacks Research analyst Team now anticipates that the scientific and technical instruments company will post earnings per share of $1.65 for the quarter, down from their prior estimate of $1.73. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Itron’s current full-year earnings is $6.01 per share. Zacks Research also issued estimates for Itron’s Q1 2027 earnings at $1.39 EPS, Q2 2027 earnings at $2.21 EPS, Q3 2027 earnings at $1.44 EPS, Q4 2027 earnings at $0.81 EPS and FY2027 earnings at $5.86 EPS.

Itron (NASDAQ:ITRI) last issued its earnings results on Tuesday, April 28th. The scientific and technical instruments company reported $1.49 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.23. The firm had revenue of $586.98 million for the quarter, compared to analysts’ expectations of $572.04 million. Itron had a return on equity of 19.54% and a net margin of 12.31%.The firm’s revenue for the quarter was down 3.3% compared to the same quarter last year. During the same quarter last year, the firm earned $1.52 earnings per share. Itron has set its Q2 2026 guidance at 1.250-1.350 EPS.

A number of other brokerages have also recently commented on ITRI. Stephens restated an “overweight” rating and set a $130.00 price objective on shares of Itron in a research note on Wednesday. Oppenheimer boosted their price objective on Itron from $133.00 to $135.00 and gave the stock an “outperform” rating in a research note on Thursday, April 16th. Roth Mkm restated a “buy” rating and set a $136.00 price objective on shares of Itron in a research note on Wednesday, April 29th. Raymond James Financial began coverage on Itron in a research note on Tuesday, April 21st. They set an “underperform” rating on the stock. Finally, Guggenheim set a $155.00 price objective on Itron in a research note on Friday, February 13th. Eight analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Itron has an average rating of “Moderate Buy” and an average target price of $131.22.

Itron Trading Up 0.6%

Shares of ITRI opened at $81.85 on Friday. The stock’s 50-day moving average is $88.63 and its two-hundred day moving average is $94.60. The stock has a market cap of $3.63 billion, a PE ratio of 13.05, a P/E/G ratio of 0.71 and a beta of 1.35. Itron has a 12 month low of $77.77 and a 12 month high of $142.00. The company has a debt-to-equity ratio of 0.97, a current ratio of 2.66 and a quick ratio of 2.24.

Insider Transactions at Itron

In other news, CFO Joan S. Hooper sold 355 shares of Itron stock in a transaction dated Wednesday, May 20th. The stock was sold at an average price of $79.60, for a total transaction of $28,258.00. Following the sale, the chief financial officer directly owned 117,920 shares of the company’s stock, valued at approximately $9,386,432. The trade was a 0.30% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Donald L. Reeves III sold 519 shares of Itron stock in a transaction dated Wednesday, February 25th. The stock was sold at an average price of $97.84, for a total value of $50,778.96. Following the sale, the senior vice president directly owned 29,951 shares in the company, valued at approximately $2,930,405.84. The trade was a 1.70% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders have sold 5,708 shares of company stock worth $521,729. Corporate insiders own 1.77% of the company’s stock.

Institutional Trading of Itron

A number of hedge funds and other institutional investors have recently modified their holdings of the business. DLD Asset Management LP increased its holdings in Itron by 49.9% in the third quarter. DLD Asset Management LP now owns 63,400 shares of the scientific and technical instruments company’s stock valued at $7,897,000 after buying an additional 21,100 shares during the last quarter. Thrivent Financial for Lutherans increased its holdings in Itron by 78.3% in the third quarter. Thrivent Financial for Lutherans now owns 77,488 shares of the scientific and technical instruments company’s stock valued at $9,653,000 after buying an additional 34,027 shares during the last quarter. Elo Mutual Pension Insurance Co bought a new stake in Itron in the third quarter valued at about $1,672,000. J. Safra Sarasin Holding AG bought a new stake in Itron in the third quarter valued at about $4,673,000. Finally, Envestnet Asset Management Inc. increased its holdings in Itron by 34.0% in the third quarter. Envestnet Asset Management Inc. now owns 148,317 shares of the scientific and technical instruments company’s stock valued at $18,474,000 after buying an additional 37,634 shares during the last quarter. 96.19% of the stock is owned by hedge funds and other institutional investors.

Itron News Summary

Here are the key news stories impacting Itron this week:

• Positive Sentiment: Stephens reaffirmed its Overweight rating on Itron and set a $130 price target, implying meaningful upside from recent levels. Stephens reaffirms Overweight on Itron
• Neutral Sentiment: Several executives sold relatively small amounts of stock, but the company said the transactions were tied to tax withholding obligations related to vesting equity awards, which makes them less concerning than open-market selling. Among the sellers were CFO Joan S. Hooper and SVPs John F. Marcolini, Justin K. Patrick, Laurie Ann Pulatie-Hahn, Donald L. Reeves III, Christopher E. Ware, and CAO David Marshall Wright.
• Negative Sentiment: Zacks Research trimmed its earnings estimates for Itron, cutting Q2 2026 EPS to $1.31 from $1.44, Q3 2026 EPS to $1.52 from $1.55, and Q1 2028 EPS to $1.77 from $1.99, while keeping a Hold rating. Zacks cuts Itron estimates
• Negative Sentiment: The same research note also nudged down FY2026 EPS to $5.97 from $5.98, signaling slightly softer near-term expectations for the business.

Itron Company Profile

Itron, Inc (NASDAQ: ITRI) is a global technology company that develops innovative solutions to measure, manage and analyze the use of energy and water. Its comprehensive portfolio includes smart meters, data collection devices, communication networks and advanced software applications designed to optimize utility operations and foster sustainable resource management. The company’s offerings enable utilities and cities to accurately monitor consumption patterns, streamline billing processes and improve grid reliability.

Itron’s product lineup spans a range of hardware and software solutions, from residential and commercial smart meters to meter data management systems (MDMS), networked communication platforms and analytics tools.